Primary Single-Stage Mastopexy Augmentation: Evaluation of Complications and Patient Satisfaction

Plastic & Reconstructive Surgery:
October 2009 - Volume 124 - Issue 4S - pp 21-22
doi: 10.1097/01.prs.0000364031.56121.f5
Saturday, October 24

Primary Single-Stage Mastopexy Augmentation: Evaluation of Complications and Patient Satisfaction

Fallucco, Michael A. MD; Desai, Ankit R. MD; Prada, Christian A. MD; Lund, Herluf G. MD; White, Bruce I. MD; Huffaker, William H. MD

INTRODUCTION:

The outcomes reviews are limited for single-stage mastopexy with breast augmentation.1–4 This study evaluates our experience with primary single-stage mastopexy with breast augmentation to determine frequencies and types of complications. Secondarily, we identify patient demographics or surgical variables that may predict complications; we review patient satisfaction, and we evaluate the added cost to our patients who experience a complication.

METHODS:

177 patient charts from a four-surgeon group were retrospectively reviewed over a seven-year period. All patients underwent primary single-stage mastopexy with augmentation. Patient satisfaction data was gathered via a telephone-based questionnaire. Major complications required a subsequent operation while minor complications were managed conservatively. We performed chi-square, step-wise logistic regression, fischer’s exact test, and Mann-Whitney-Wilcoxon tests.

RESULTS:

The overall major and minor complication rates were 11.8% and 14.1%, respectively. Patients with a preoperative ASA ≥ 2 had a 3.44 times, and the vertical mastopexy group had a 3.34 times increased likelihood of a minor complication (p < .01). Increases in BMI, ptosis, SSN-N and IMF-N distances demonstrated a rise in clinical frequencies of complications, with only the IMF-N distribution statistically significant at p < 0.01. Neither the implant location, volume, surface or type were independent risk factors for increased complications. There were 105 respondents (59%) to the follow-up questionnaire. 90% were either satisfied or extremely satisfied with respect to grading their overall results and to whether surgery met their goals.

The median resource cost for patients who experienced a major complication versus those without a complication rose by $765; and those who experienced a minor complication incurred an additional $485 (p < .001).

CONCLUSION:

Single-stage mastopexy with augmentation can be performed with low complications. This study highlights factors for both the surgeon and patient to be aware of in the pre-operative consultation that may help to set appropriate expectations.

REFERENCES:

1. Spear, S. L. Augmentation/mastopexy: “Surgeon, beware.” Plast Reconstr Surg 112; 905-906; 2003. Cited Here...

2. Stevens, W. G., Freeman, M. E., Stoker, D. A., Quardt, S. M., Cohen, R., Hirsch, E. M. “One-Stage Mastopexy with Breast Augmentation: A Review of 321 Patients.” Plast Reconstr Surg 120;1674-1679; 2007. Cited Here...

3. Spear, S. L., Boehmler IV, J. H., Clemens, M. W. “Augmentation/Mastopexy: A 3-Year Review of a Single Surgeon’s Practice” Plast Reconstr Surg 118;136S-147S; 2006. Cited Here...

4. Spear, S. L., Pelletiere, C. V., and Menon, N. “One-stage augmentation combined with mastopexy: Aesthetic results and patient satisfaction.” Aesth Plast Surg 28; 259-267; 2004. Cited Here...
Back to Top | Article Outline
DISCLOSURES:

Herluf G. Lund is a consultant for Allergan, Inc.

©2009American Society of Plastic Surgeons